RE: Only one reason!
Again its hard not to agree with you... although in all fairness, they really have done SOME things right to further and protect the technology, and to advance its acceptance.... all of which is contributing to the recurring revenue and the solid contracts they do have... The problem is... too many of them are very back-ended.
Frustrating to say the least to see the whack of shares on the offer here at 13-13.5, with no one really prepared to step up meaningfully. I cant help but notice Paradigm's absence in the trading...
Ironically, I posted here some time ago that I had talked with Pierre at length about my suggestion to him that they hire a credible investment bank to effectively auction 1402 to the best partner / licensee...
If you take the "glass half full approach", you might assume they only took this tact with Japan because they are well down the path with another company for Europe and North America... Fortunately / Unfortunately .. Pierre has been saying that for a long time... but its always "hurry-up-and-wait " ....and with little credibility, there is literally no reflection in the stock.
The only thing I will say is this, while many of the best initiatives have been LATE, most of the important ones have either improved or have ultimately come together, especially related to the commerical prion removal intiatives... and the whole purification side with various Bios and Pharms. I have and will continue to bet with my shares that this is a waiting game story requiring significant patience.